Platform 2
The tumor becomes
the teacher.
Personalized whole-tumor-cell cancer vaccines. Built from the broad antigen repertoire available in the patient’s own tumor, without prior antigen selection.
Investigational. Patient safety and efficacy have not been established.
Film unavailable.
Immune education
From tumor antigens
to T-cell recognition.
Different cancer cells can carry different antigens. Immune education depends on uptake, processing, and peptide presentation.
The goal: broad recognition and lasting immune memory.
Local manufacturing
Personalized input.
Made where care happens.
One integrated, automated-process vision across treatment centers. Keep the patient, tumor material, and vaccine workflow connected.
Patient’s tumor material
Collected after surgery
Local production
Integrated manufacturing
At the treatment center
Fewer handoffs
Personalized vaccine
Patient-specific output
A path to wider access
What is a personalized cancer vaccine?
A cancer treatment vaccine aims to teach the immune system to recognize cancer. Personalized means its targets come from the individual patient; PyroCells uses tumor material collected after surgery as its starting point.
Connect